pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$TNXPTonix Pharmaceuticals Holding Corp.

$TNXP12.39-2.67%
Berkeley Heights, NJ, USupdated 6h ago

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
7
marketed
2
phase 3
0
catalysts ytd
3
approvals ytd
0
recalls ytd
0

Pipeline(7)

pipeline depth7 products
Preclinical: 2Phase 1: 2Phase 2: 1Marketed: 2
2Preclinical2Phase 11Phase 22Marketed
Marketed
Tosymra
Migraine
Marketed
Zembrace Symtouch
Migraine
Phase 2
cyclobenzaprine hydrochloride
Acute Stress Disorder
5-hydroxytryptamine receptor 2A5-hydroxytryptamine receptor 2C
Phase 1
TNX-1500
Heart Transplant Rejection
Phase 1
TNX-4800
Lyme Disease
Preclinical
TNX-1700
Colorectal Cancer
Preclinical
TNX-801
Monkeypox

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

earnings (1)
Aug 10, 2026
earnings
$TNXP12.39-2.67%
11d ago
Tonix Pharmaceuticals Holding Corp. earnings
Tonix Pharmaceuticals Holding Corp.
→
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Mar 31, 26BUYLEDERMAN SETH· Chief Executive Officer5,000 sh @ $12.62$63K↗
  • Mar 18, 26BUYLEDERMAN SETH· Chief Executive Officer15,000 sh @ $14.89$223K↗
routine RSU / option mechanics (6)
  • Feb 24, 26grantMORRIS JESSICA EDGAR · Chief Operating Officer39,012 sh
  • Feb 24, 26grantMORRIS JESSICA EDGAR · Chief Operating Officer39,011 sh
  • Feb 24, 26grantSAENGER BRADLEY · Chief Financial Officer39,012 sh
  • Feb 24, 26grantSAENGER BRADLEY · Chief Financial Officer39,011 sh
  • Feb 24, 26grantSULLIVAN GREGORY M · Chief Medical Officer39,012 sh
  • Feb 24, 26grantSULLIVAN GREGORY M · Chief Medical Officer39,011 sh
🐶 Hiring Signal
No open roles indexed yet — view Tonix Pharmaceuticals Holding Corp. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$TNXP
SEC CIK
0001430306
country
US
source
sec_tickers
top tags
Infectious Disease2Colorectal Cancer1Immunology1Lupus1Oncology1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 15m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?